Censo Biotechnologies

Censo Biotechnologies Ltd is a stem cell technology company providing human cells and contract research services for drug discovery, toxicity testing and cell banking.

The company has the capabilities to generate induced pluripotent stem cells (iPSCs) from large cohorts of individuals and use the potential of these cells to create virtually any cell in the human body.

By developing cell-based models of disease using cells from a diverse range of tissue donors, the company supports the development of new targeted treatments for disease. Its major focus is the generation of novel data on drug efficacy and drug response variation for a given population.

The company was founded in 2016, through the merger of Roslin Cellab and Roslin Cell Sciences, and has facilities in both Edinburgh and Cambridge, UK.

Chiltern

Chiltern is the leading, global mid-sized contract research organization. We listen to client needs to deliver customized clinical development solutions with a team of more than 4,000 working across 47 countries to provide comprehensive, yet flexible and responsive, services with specialties in Clinical Development, Oncology, Device & Diagnostics, Data, Analytics & Evaluation and Strategic Service Provision.
Company Type
Company Sub-Type
Twitter Account
@chiltern_CRO

CLINICAL ACCELERATOR

Clinical Accelerator conducts all phases of clinical trials for pharma, biotech and medtech companies. We have a very simple mission: to accelerate clinical development projects and to reduce their cost appreciably for our clients. We use several strategies to achieve very compact timelines in our clinical studies: - optimization of study design (only necessary outcome measures and end-points, right number of patients, optimal follow-up duration) - selection of effective investigative sites located in our region of operation. All our sites, conducting trials to the highest standards of GCP, have a large patient recruiting capacity and a proven track record of efficient timely recruitment of qualified patients. - accelerated start up (fast regulatory and IRB/EC approval times, streamlined logistics, expedited contracting, fast site activation, USA IND or EU CTA are optional in our region of operation) - effective patient enrolment and retention (dedicated department, proven region-specific patient recruitment strategies) We are specialists in effective and timely patient recruitment, and commit to achieving patient enrolment targets within fixed timelines. We routinely rescue stalled clinical trials. We are able to reduce the cost of our clinical projects significantly due to our: - flat organizational hierarchy, reasonable service rates and very modest internal overhead costs - commitment to agreed fixed budgets (rare need for change orders) - modest investigator grants and low hospital overheads in our region of operation (very large savings can be achieved in many therapeutic areas) - use of as few locations and as few investigative sites as possible without compromising patient recruitment rates (this limits set-up costs and lowers per patient cost) - short study timelines, which lead to reduced management costs - potential risk sharing (optional strategy) The cost of our studies is among the most attractive globally. We commit to our budgets and fix them for our clients.
Company Type
Company Sub-Type
Twitter Account
@clinaccelerator

Clinical Network Services (CNS) Ltd

Clinical Network Services (CNS) is an integrated service group focused on product development headquartered in Australia with offices in New Zealand, the UK and the USA. CNS creates value for small-medium sized biotechnology companies by progressing early stage products through phase 1 & 2 clinical trials or the marketplace sooner.

CNS offers a unique service where it integrates BioDesk, an intelligent global product development and regulatory affairs consultancy, with our committed, highly experienced Australian/New Zealand clinical operations and biometrics team. BioDesk’s expert consultants offer CMC/manufacturing, toxicology, clinical and regulatory affairs strategic advice and guide products efficiently through critical post-discovery development and into the clinic for the first time.

With over 15 years’ experience on more than 300 projects, CNS is one of the most experienced providers within the local market and a partner of choice for biotech companies. CNS’s small-medium size is considered a big advantage when relating to similar sized clients, though CNS takes a global development/ regulatory approach to ensure value is strategically added at every stage of the product development life cycle. 

Company Type
Company Sub-Type
Twitter Account
n/a

Custom Pharmaceuticals

Custom Pharmaceuticals is a privately owned company spanning two MHRA approved sites based in Hove and Moulsecoomb near Brighton, employing approximately 185 people and manufacturing circa 1.5 billion tablets and 250 million capsules per year.
The company, is able to offer expertise in the manufacture, analytical testing and packing of solid dose medicinal products across a range of therapeutic areas to a wide range of clients. In addition, the organisation is able to offer to the marketplace, expertise and assistance in new and existing product development, regulatory support and also technical support for ongoing client projects.
Company Type
Company Sub-Type
Twitter Account
@Custom_Pharma

Datatrial Ltd

Datatrial was founded as a technology company in 1999 with a focus on developing software that would improve the clinical research process. Our goal today remains to allow you to realise the benefits of speedy, real-time access to information helping you to identify, gather and respond to any actions and issues as quickly as possible.
With an in-house team of developers continually improving our products we will ensure we have a simple solution to offer you for all your clinical research needs.

 

Datatrial Nucleus
Nucleus is a collaboration tool that brings people, applications and documents together in a single compliant environment. Unlike other vendors in our space, the platform is software agnostic allowing inclusion of other third party solutions. Access can be achieved via single sign on or addition of the relevant link within the Nucleus platform. This enables us to include any number of technologies that may be of value to our customers whilst being aware of industry and legal requirements around data and privacy. With the move towards patient centred research, Nucleus can also provide a place where patients can see their data and also communicate with the key people working in their trial.
nowEDC 
Collect, manage and report on your clinical data from a single, scalable system.
Whether at the very start or nearing the end of your trial, nowEDC will increase your visibility of the data your sites are working hard to collect, providing you with clean, consistently reliable data.

Company Type
Company Sub-Type
Keywords
Twitter Account
@Datatrial

Domainex Ltd

Domainex is a drug discovery company with a reputation for speed and innovation built on an exceptional track record of drug candidate delivery. It has a world class discovery team with an unrivalled track record and three client drug candidates.
Company Type
Twitter Account
@Domainex_UK

Dora Wirth Languages Ltd

Established in 1962, Dora Wirth Languages Ltd. (DWL) has over 50 years of excellence in global translation solutions for the life science industry. The DWL approach is built on a solid foundation of experience and in-house medical expertise, using DWL’s well-practised and specially formulated procedures for translation, project management and quality control. DWL's business has grown through a dedication and commitment to quality and service. This is acknowledged by DWL's many long-standing clients and is most clearly demonstrated by their recommendation of DWL to others.
Company Type
Company Sub-Type
Twitter Account
@DWLanguages

Embassy Freight Services

Established in 1994, Embassy Freight Services are a Global Logistics company operating from forty-five offices worldwide with three offices in the UK - Basildon, Heathrow and Manchester. We are a progressive company that looks to provide innovative solutions that ensure our customers' supply chains are a competitive advantage.

We make it our business to deliver on our commitments with honesty and responsibility so that we can be relied upon. To fulfil such commitments we established a team of staff providing a personal, dedicated service backed up by an advanced and flexible I.T. infrastructure. For the diverse requirements of our clients our philosophy remains the same: to understand the clients business needs, to accept the challenge to deliver, manage the risks to cargo and protect the commercial transaction.

Company Type
Company Sub-Type
Twitter Account
#EmbassyFreight

ERA Consulting

ERA is able to contribute at any stage of product development, from discovery, through process development, non-clinical and clinical aspects, to regulatory approval and beyond. One of our recognised specialities is the design of a regulatory strategy, to cover part or all of the development process. Thus, our services include the following: Regulatory due diligence exercises for in- or out-licensing, interactions with regulatory agencies, such as pre-IND, pre-BLA and scientific advice procedures, clinical trial applications, marketing authorisation applications, including eCTD submissions, post-approval amendments or variations, advice on process development, including validation, input on characterisation and control, consulting on non-clinical and clinical strategy, facility inspections and support for establishment licensing.